INCORPORATING INNOVATIVE NANOTECHNOLOGY EPILEPSY TREATING DEVICE IN NURSING MANAGEMENT OF ADULT PATIENTS WITH EPILEPSY: COVID19 PANDEMIC CONSIDERATION
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 2, Pages 625-637
AbstractEpilepsy is a disease categorized by a spontaneous repetition of unprovoked seizures, is one of the most widespread chronic neurological states. the rate of its prevalence is reported to be 0.7–1.0% (Fiest, Sauro, Wiebe, Patten, Kwon & Dykeman, 2017). The Center for Disease Control and Prevention (CDC) proposes that neurological comorbidities, including epilepsy, could be a risk factor for COVID-19(Kuroda, 2020). The concern of the COVID19 pandemic toward patients with epilepsy include the fact that Frequent seizures would cause malnutrition, and the nutritional status is associated with the immune system (Crepin, Godet, Chassain, Preux&Desport, 2009). On the other hand, going to emergency rooms because of increased or uncontrollable seizures could expose the patient to coronavirus. Therefore, it's crucial to consider innovative ways to detect and control seizures among these patients.
- Article View: 144
- PDF Download: 157